Xu-Monette, Z. Y., Li, J., Xia, Y., Crossley, B., Bremel, R. D., Miao, Y., . . . Young, K. H. (2019). Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer.
シカゴスタイル引用形Xu-Monette, Zijun Y., et al. "Immunoglobulin Somatic Hypermutation Has Clinical Impact in DLBCL and Potential Implications for Immune Checkpoint Blockade and Neoantigen-based Immunotherapies." J Immunother Cancer 2019.
MLA引用形式Xu-Monette, Zijun Y., et al. "Immunoglobulin Somatic Hypermutation Has Clinical Impact in DLBCL and Potential Implications for Immune Checkpoint Blockade and Neoantigen-based Immunotherapies." J Immunother Cancer 2019.